ImmunoGenesis
ImmunoGenesis is a startup headquartered in Doylestown, United States, founded in 2019. It has raised at least $50.2m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
ImmunoGenesis has raised at least $50.2m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
ImmunoGenesis sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Doylestown
Related
Questions and answers
What does ImmunoGenesis do?
ImmunoGenesis is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has ImmunoGenesis raised?
At least $50.2m, according to its Form D filings with the US Securities and Exchange Commission.
Where is ImmunoGenesis based?
ImmunoGenesis is headquartered in Doylestown, United States.
When was ImmunoGenesis founded?
ImmunoGenesis was founded in 2019.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.